High cholesterol contributes to over a third of coronary heart disease burden. Despite well-established evidence supporting the benefits of cholesterol lowering for the prevention of cardiovascular disease (CVD), many patients fail to meet their lipid targets.
Hosted by the Heart Foundation in partnership with the World Heart Federation, this webinar will explore the latest evidence around screening and management of high cholesterol for the reduction of CVD risk.
The panel will explore the practical implementation of emerging evidence and tools and resources that can help improve the delivery of preventative CVD assessments in primary care.
- The relationship between lipid biomarkers and CVD risk, including novel markers such as Lp(a)
- Practical update on new lipid-lowering therapies for the prevention and treatment of CVD, including PCSK9 inhibitors and other therapies on the horizon
- Brief introduction to the screening and diagnosis of familial hypercholesterolaemia in primary care
- What general practices can do to champion CVD prevention and implement structured screening programs
- International guest speaker: Prof. Pamela Morris (Medical University of South Carolina)
- Prof. Gerald Watts (University of Western Australia)
- A/Prof. David Sullivan (University of Sydney)
- Prof. Garry Jennings (Chief Medical Advisor of the Heart Foundation)